GalaFLEX Breast Mesh Lawsuit [2026 Update]

What Is GalaFLEX?

GalaFLEX is a synthetic surgical scaffold made from a bioresorbable polymer called poly-4-hydroxybutyrate (P4HB) that is cleared for use in reinforcing and repairing soft tissue in plastic and reconstructive procedures, including some medically necessary breast surgeries, where extra support may be desired.

The GalaFLEX products are part of a broader family of BD mesh products that include variations like GalaFLEX LITE, GalaFLEX 3D and GalaFLEX 3DR, each designed as a mesh-like support structure to be used alongside sutures where tissue weakness or gaps exist.

In clinical practice, plastic surgeons may elect to use GalaFLEX as an adjunct for patients with compromised or weak breast tissue, including during procedures such as breast revision, mastopexy, or breast augmentation, where additional internal support is considered helpful.

Surgeons sometimes refer to this application as an internal bra technique or internal bra breast lift, because the mesh can provide a temporary scaffold intended to help maintain shape and position while the body heals.

The material is designed to gradually absorb over time, typically within roughly 12 to 18 months, as the body’s own collagen and natural tissue grow into and replace the mesh’s scaffold structure.

Although some surgeons and promotional materials describe potential benefits, the underlying science includes a foreign-body response and integration that varies from patient to patient, and early outcomes do not guarantee long-term results in every case.

The FDA has communicated that no surgical mesh, including GalaFLEX, has been cleared or approved specifically for use in breast reconstruction or breast augmentation, and health care providers are encouraged to follow labeled instructions and carefully evaluate risks when using mesh in these contexts.

Some reports and product information note that implantation can be associated with complications such as infection, seroma, pain, scaffold migration, wound problems, or inflammation, among other potential risks.

GalaFLEX’s use reflects evolving clinical practice rather than a universally agreed-upon standard of care, and patients sometimes learn after the fact that the product was part of their surgery.

Because of these factors, independent evaluation of risks, benefits, and long-term outcomes remains an active discussion among plastic surgeons, health care providers and patients considering synthetic mesh for extra support in breast procedures.

How GalaFLEX Is Used in Breast Surgery and Internal Support Techniques

In internal bra surgery, surgeons may place GalaFLEX as an internal support layer to reinforce soft tissue and help stabilize a breast implant during healing.

The scaffold is typically sutured to existing structures so it can provide temporary reinforcement while the body lays down new collagen around the area.

Although GalaFLEX is a synthetic mesh, it is sometimes discussed alongside biologic support options such as an acellular dermal matrix, since both involve adding foreign material to support breast tissue when native tissue alone may not provide enough strength.

The choice between these materials can depend on surgeon preference, patient anatomy, and the specific goals of the procedure.

GalaFLEX is commonly used in the following ways:

• Reinforcing the lower pole to reduce stretch and support implant position
• Creating an internal sling to stabilize a breast implant pocket during revision or reconstruction
• Supporting weakened tissue in mastopexy or augmentation-mastopexy cases
• Providing additional reinforcement in areas where tissue quality is thin or compromised

FDA Communications and Labeling Language on Surgical Mesh in Breast Surgery

FDA communications matter in internal bra cases because they frame what the agency has and has not determined about surgical mesh used in breast surgery.

The FDA warns that the safety and effectiveness of surgical mesh in breast surgery, including augmentation and reconstruction, has not been determined by the FDA, and it also states there are no surgical mesh products cleared or approved by the FDA specifically for breast surgery.

The FDA has also addressed differing complication rates across acellular dermal matrix products used in implant-based breast reconstruction, which is relevant when patients report infections, implant loss, and other outcomes that lead to additional surgeries.

For claim review, these communications do not substitute for medical proof, but they provide context that can be compared against operative reports and the documented course of complications and revisions.

When the FDA discusses “labeling updates,” it is referring to warnings and precautions in product labeling for certain BD mesh products, not a recall or a ban.

FDA communications and related notices:

• FDA “In Brief” (March 31, 2021): ADM products used in implant-based breast reconstruction differ in complication rates: FDA warns that some ADM products showed higher chances of complications or problems in implant-based breast reconstruction, which can include outcomes that drive reoperations and implant removal.
• FDA GovDelivery bulletin (April 2021): Safety Communication distribution to patients/caregivers/health care providers: A republished FDA notice reiterating that certain ADM products used in implant-based breast reconstruction may have a higher chance of complications or problems.
• FDA Letter to Health Care Providers (Nov. 9, 2023): Labeling updates for BD mesh products: The FDA communicates updated warnings and precautions for certain BD mesh products and reiterates that safety and effectiveness of surgical mesh in breast surgery has not been determined by the FDA.
• FDA GovDelivery bulletin (Nov. 2023): Labeling updates summary: FDA’s bulletin version of the provider letter, repeating the FDA’s position that no surgical mesh products are cleared or approved for breast surgery and referencing labeling updates.
• FDA patient guidance page: “Breast Implant Surgery” (ongoing guidance): FDA explains what surgical mesh is (including ADM) and prompts patients to discuss complications, reoperation risk, and what additional surgeries may be required over a lifetime with their surgeon, which can be cross-checked against operative reports and revision history.

Potential Complications Following Breast Surgery Involving Mesh or Scaffolds

Breast surgery that incorporates mesh or scaffold materials is intended to add structural support when a patient’s tissue may not provide enough stability on its own.

Even when placement is technically successful, healing varies, and some patients develop serious complications that require additional treatment or revision surgery.

Early problems may involve fluid collections, wound breakdown, or infection that disrupts integration between the material and the surrounding tissue.

In some cases, inflammation or scarring changes how the breast heals, which can affect implant position and long-term comfort.

When scarring becomes aggressive, capsular contracture can develop, tightening around the implant and causing firmness, pain, and visible distortion.

Patients may also report nerve damage or persistent sensitivity, particularly when swelling and scar tissue affect nearby nerves.

These outcomes are evaluated based on the documented injuries suffered, the timing of symptoms, and what operative records show about the material used and the condition of the patient’s tissue.

Commonly reported complications and injuries following breast surgery involving mesh or scaffolds include:

• Surgical site infection or deep infection involving the implant pocket
• Seroma or persistent fluid buildup requiring aspiration or additional drains
• Delayed wound healing, wound dehiscence, or incision breakdown
• Tissue damage involving thin skin flaps or compromised circulation
• Tissue death, including skin necrosis that may require debridement
• Mesh migration or shifting of the scaffold from its intended position
• Implant malposition, asymmetry, or contour deformity linked to loss of support or scarring
• Capsular contracture, including painful tightening and breast distortion
• Chronic pain, nerve pain, or nerve damage symptoms such as burning, numbness, or hypersensitivity
• Implant exposure, mesh extrusion, or tissue erosion that increases infection risk
• Need for revision surgery, implant exchange, or implant removal

Not every complication is caused by the mesh itself, and breast surgery can carry known risks even without added materials.

The clinical question is often whether the recovery course aligned with what would be expected in routine healing, or whether complications escalated in a way that required repeated intervention.

Operative reports, follow-up notes, imaging when available, and revision records usually provide the clearest timeline.

When a claim is evaluated, the focus stays on what can be documented, how the complications progressed, and the medical treatment required to address tissue damage, implant malposition, or other serious complications.

When a Post-Surgical Complication Becomes a Legal Claim

Many patients experience some pain, swelling, and healing delays after reconstructive surgery, and those outcomes alone do not automatically point to a product-related claim.

A legal claim is more likely to be evaluated when complications are serious, persistent, or require additional surgeries such as revision, washout, or implant removal.

These reviews typically focus on the facts that can be verified in the medical record, including what material was implanted, how it was placed, and when symptoms began.

Product identification matters, and operative reports or implant logs may show the brand, lot number, or other device identifiers needed to confirm what was used.

The medical timeline also matters, because it can show whether complications developed soon after implantation or after a later event such as infection, trauma, or a separate procedure.

When lawyers assess a case, they generally look for documentation that connects the complication history to specific treatment needs and measurable losses, rather than relying on assumptions about causation.

Do You Qualify for a GalaFLEX-Related Claim Review?

A GalaFLEX-related claim review usually starts with two questions: whether GalaFLEX was used in your procedure and whether you experienced complications that required additional treatment after implantation.

Some claims assert that manufacturers failed to disclose known risks of using mesh in delicate breast tissue to both surgeons and patients, and that warnings did not match the complication profile reported in certain cases.

Breast mesh lawsuit allegations also include marketing-related claims, including assertions that absorbable mesh was promoted for breast lifts and breast reconstruction in ways that went beyond the product’s FDA-cleared indications.

Lawsuits may allege the mesh was presented as an “internal bra” option for breast reconstruction without specific FDA approval for breast surgery, and that doctors and patients were not adequately warned about the risks of placing mesh in delicate breast tissue.

In practice, many claim reviews focus on whether the complication history involved painful complications, infection, wound breakdown, mesh exposure, chronic inflammation, implant problems, or multiple surgeries.

Product identification is critical, so operative reports, implant logs, device stickers, and any Unique Device Identifier information can determine whether GalaFLEX was used.

Even when complications are severe, eligibility depends on what the records show and whether the evidence supports the allegations being evaluated.

Consulting a licensed attorney is essential to determine whether your circumstances may qualify for an internal bra lawsuit based on your surgery, injuries, and documentation.

Gathering Evidence for a GalaFLEX Breast Mesh Claim

To start an internal bra mesh claim, you’ll need to gather evidence that shows what product was implanted, when symptoms began, and what medical care followed.

Product identification often depends on surgical records, and you can sometimes confirm the mesh by locating device stickers, a Unique Device Identifier (UDI), and the device lot number in your chart.

Evidence also matters because you may still have a claim even if your symptoms appeared years later, as long as the timeline and medical documentation support what happened.

If you undergo revision surgery, you should not discard removed mesh material, since it can serve as evidence in your case.

Evidence that may be important includes:

• Operative reports and surgeon notes describing the mesh placement and the purpose of the internal support
• Implant logs, device stickers, UDI information, and device lot or catalog numbers
• Hospital and clinic follow-up notes documenting symptoms, complications, and treatment decisions
• Imaging records, when used to evaluate fluid collections, implant position, or suspected complications
• Lab results and culture reports if infection was suspected or confirmed
• Revision or removal surgery records, including pathology or explant documentation
• The removed mesh material itself, if it was explanted, preserved, and documented through the facility chain of custody
• Itemized medical bills and insurance statements showing costs of treatment and repeat procedures
• Employment and wage records showing time missed from work or reduced earning capacity
• A personal timeline of symptoms and key treatment events to align with the medical chart

Your lawyer can tell you exactly what evidence you will need for your individual claim, based on your surgery history and complications.

If you are missing records, hospitals and surgical centers often maintain implant documentation that can be requested directly.

Acting sooner rather than later can matter because statutes of limitations vary, and preserving medical records and any removed material is easier closer to the time of treatment.

Potential Damages in Breast Mesh Claims

Damages are the losses a person claims after an injury, and they can include both financial costs and the personal impact of the complications.

Patients who experienced complications from an Internal Bra System may be entitled to compensation, depending on the medical evidence and the circumstances of the procedure.

Potential compensation in an internal bra lawsuit may include economic and non-economic damages, which are evaluated based on documentation rather than assumptions.

Lawyers typically perform a comprehensive review of medical records, billing statements, employment documentation, and the treatment timeline to assess what the complications cost and how they changed the person’s day-to-day life.

The goal is to present damages in a clear, provable way that matches the severity of the injuries and the long-term impact.

Damages may include:

• Past medical expenses, including hospital care, antibiotics, imaging, and wound treatment
• Future medical care costs, including revision surgery, implant exchange, or implant removal
• Costs related to reconstruction changes, staged procedures, and follow-up appointments
• Lost wages and reduced earning capacity from missed work or lasting limitations
• Physical pain and ongoing symptoms, including chronic pain
• Emotional harm, including anxiety, depression, or distress related to complications and body changes
• Scarring, tissue loss, and permanent disfigurement
• Out-of-pocket expenses such as prescriptions, medical supplies, travel, and caregiving needs
• Loss of enjoyment of life and reduced ability to participate in normal activities

TorHoerman Law: Reviewing Breast Mesh Claims Involving GalaFLEX

Breast mesh claims involving GalaFLEX often depend on careful review of surgical records, complication timelines, and the medical treatment required after implantation.

When recovery deviates from what would typically be expected and leads to repeated procedures, prolonged pain, or lasting changes, the details matter.

TorHoerman Law reviews these cases by focusing on documentation, product identification, and how the complication history affected the patient’s health and quality of life.

If you believe a GalaFLEX mesh or internal bra procedure contributed to serious complications, TorHoerman Law can evaluate your records and explain whether your circumstances may support a claim.

Contact TorHoerman Law to request a confidential case review and learn what next steps may be available.